Literature DB >> 15738441

Blinkered objections to bioethics: a response to Benatar.

J Taylor1.   

Abstract

In a recent commentary, S R Benatar criticised the debates over organ donation and kidney selling for being located within a "narrow and inadequate framework". Benatar levels four charges against those who engage in the current organs debate: that they myopically focus on saving lives; that they accept the dominance of market orientated approaches to health care; that they reify individualism, and that they engage in limited moral arguments. Given the importance of the organs debate it is imperative that the misunderstandings of it on which Benatar's criticisms are based are dispelled. Accordingly, I will consider and reject each of his objections in turn.

Keywords:  Health Care and Public Health; Philosophical Approach

Mesh:

Year:  2005        PMID: 15738441      PMCID: PMC1734114          DOI: 10.1136/jme.2004.010322

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  7 in total

1.  Markets and the needy: organ sales or aid?

Authors:  T L Zutlevics
Journal:  J Appl Philos       Date:  2001

Review 2.  Drug development for neglected diseases: a deficient market and a public-health policy failure.

Authors:  Patrice Trouiller; Piero Olliaro; Els Torreele; James Orbinski; Richard Laing; Nathan Ford
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

3.  Selling yourself: Titmuss's argument against a market in blood.

Authors:  David Archard
Journal:  J Ethics       Date:  2002

4.  Blinkered bioethics.

Authors:  S R Benatar
Journal:  J Med Ethics       Date:  2004-06       Impact factor: 2.903

5.  An ethical market in human organs.

Authors:  Charles A Erin; John Harris
Journal:  J Med Ethics       Date:  2003-06       Impact factor: 2.903

Review 6.  Nephrarious goings on. Kidney sales and moral arguments.

Authors:  J R Richards
Journal:  J Med Philos       Date:  1996-08

7.  Buying human kidneys: autonomy, commodity and power.

Authors:  B Brecher
Journal:  J Med Ethics       Date:  1991-06       Impact factor: 2.903

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.